Month: December 2020

Amsterdam, December 10, 2020 – Arcadis (EURONEXT: ARCAD), the leading global Design & Consultancy organization for natural and built assets, today announced that it has been awarded a contract by California’s Department of Resources Recycling and Recovery (CalRecycle) to be the primary consultant for wildfire debris and hazard tree removal in Southern California, following the state’s devasting wildfire season.The total project is valued at $52.4 million and encompasses an estimated 823 properties and 120,000 hazard trees in Los Angeles, Fresno, Madera and Tulare counties. A team of approximately 200 biologists, archaeologists, geologists, industrial hygienists, arborists and foresters will work together to manage the region’s safe restoration and improve wildfire resilience.Debris and hazard tree removal requires a complex understanding...

Elis étend la maturité de sa ligne de crédit renouvelable de 500 millions d’eurosSaint Cloud, le 10 décembre 2020 – Elis annonce avoir étendu de 12 mois, avec une option d’extension complémentaire de 6 mois, sa ligne de crédit renouvelable souscrite en janvier 2017 auprès d’un pool de banques françaises et européennes relationnelles pour un montant de 500 millions d’euros.La nouvelle échéance de cette facilité est ainsi portée à janvier 2023, avec la possibilité pour Elis d’activer une extension supplémentaire de 6 mois, ce qui porterait ainsi la maturité finale du crédit à juillet 2023.Par ailleurs, Elis dispose toujours d’une seconde ligne de crédit renouvelable de 400 millions d’euros, échéance novembre 2023.Cette opération permet donc au Groupe d’aligner les échéances de ses deux facilités de crédit renouvelable, et d’améliorer ainsi...

VANCOUVER, British Columbia, Dec. 10, 2020 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, is pleased to announce that it has engaged a globally recognized operations, compliance, and regulatory consulting firm to advise on the Company’s application to Health Canada for a Dealers Licence under the Controlled Drugs and Substances Act (CDSA).The CDSA and its Regulations provide, among other things, the framework for legal access to controlled substances, and the control and regulation of production, distribution, and sale. One of Health Canada’s responsibilities is to provide the licensing and oversight framework for the legal production of controlled substances.Under...

SAN DIEGO, Dec. 09, 2020 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis 16,666,667 shares of common stock of the Company, at a price to the public of $4.50 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about December 14, 2020, subject to satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.The Company also has granted to the underwriter a 30-day option to purchase up to an additional 2,495,000 shares of common stock...

If approved, aducanumab would become the first treatment to meaningfully change the course of Alzheimer’s diseaseAducanumab is now under regulatory review in Japan, Europe and the United StatesCAMBRIDGE, Mass. and TOKYO, Dec. 09, 2020 (GLOBE NEWSWIRE) — Today, Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) announced that Biogen has submitted a Japanese New Drug Application (J-NDA) to the Ministry of Health, Labor and Welfare (MHLW) for aducanumab, an investigational therapy for Alzheimer’s disease. Aducanumab, an amyloid beta-targeting antibody, has been shown in clinical trials to remove amyloid beta in the brain and significantly slow clinical decline in patients with Mild Cognitive Impairment (MCI) due to Alzheimer’s disease and mild Alzheimer’s disease dementia.“Japan is the third market where we have applied for...

VANCOUVER, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) — Affinor Growers Inc. (“Affinor” or the “Company”) (CSE: AFI) (OTCQB: RSSFF) is pleased to announce that the United States Patent and Trademark Office has issued U.S. Patent No. 10,842,084 (“Patent 084”) on November 24, 2020 in relation to the Company’s vertical growing technology.The Company’s initial robust design was a breakthrough in vertical farming technology. Patent 084 is heavily based on the Company’s initial concept but streamlines the design for ease of manufacturing, shipping, maintenance, and harvesting. The improvements will enable the Company to reduce costs and distribute to wider markets.About AffinorAffinor is a publicly traded company on the CSE under the symbol “AFI” and on the OTCQB under the symbol “RSSFF”. Affinor is focused on developing...

BURLINGAME, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc. (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint pathway, today announced the pricing of an upsized underwritten public offering of 2,380,000 shares of its common stock at a price of $76.00 per share. All of the shares of common stock are being offered by ALX Oncology. The gross proceeds to ALX Oncology from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by ALX Oncology, are expected to be approximately $180.9 million, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on December 14, 2020, subject to the satisfaction of customary closing conditions. In addition,...

VANCOUVER, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) — Pender Growth Fund Inc. (TSXV: PTF) (“Pender Growth Fund” or the “Company”) announces today that it has agreed to participate in GreenSpace Brands Inc.’s (TSX-V: JTR) (“Greenspace”) proposed brokered private placement (the “Greenspace Offering”).It is anticipated that Pender Growth Fund will acquire 47,191,465 units of Greenspace (“Greenspace Units”) at a price of $0.05 per Greenspace Unit for a purchase price of approximately $2.4 million. In addition, it is anticipated that Pender Growth Fund’s manager, PenderFund Capital Management Ltd. (“PenderFund”) will acquire 32,808,535 Greenspace Units on behalf of certain investment funds it manages. As used herein, “Pender” refers to Pender Growth Fund and PenderFund collectively.Each Greenspace Unit consists of one common...

AUSTIN, Texas, Dec. 09, 2020 (GLOBE NEWSWIRE) — Open Lending Corporation, (“Open Lending”) (Nasdaq: LPRO), a leading provider of lending enablement and risk analytics to credit unions, regional banks and captive finance companies of Original Equipment Manufacturers, announced today the pricing of a secondary public offering of 9,500,000 shares of its common stock at a public offering price of $28.00 per share. The offering was upsized from the previously announced offering size of 8,000,000 shares. All shares are being sold by existing stockholders, including Nebula Holdings, LLC., a True Wind Capital, L.P. managed entity, Bregal Sagemount and certain executive officers of Open Lending. The selling stockholders have also granted the underwriters a 30-day option to purchase up to 1,425,000 additional shares of common stock. Open...

TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres” or the “Trust”) (TSX:SRU.UN) announced today the voting results from its Annual General and Special Meeting of the Holders of Units and Special Voting Units (the “Meeting”) held today.The total number of Units and Special Voting Units of SmartCentres (“Units” and “SVUs”, respectively) represented by holders of Units and SVUs (collectively, “Unitholders”) that voted in connection with the Meeting was 91,622,409 Units and 35,804,536 SVUs, representing in total 70.61% of SmartCentres’ issued and outstanding Units and SVUs. At the Meeting, Unitholders voted in favour of all items of business, including the election of each of the six trustee nominees proposed by management. The voting results for the election of trustees based on the...